Zobrazeno 1 - 5
of 5
pro vyhledávání: '"You-Chia Chu"'
Autor:
Ying‐Chang Tung, Chia‐Pin Lin, Fu‐Chih Hsiao, Chien‐Te Ho, Hsu Tzyy‐Jer, You‐Chia Chu, Wen‐Jone Chen, Pao‐Hsien Chu
Publikováno v:
The Journal of Clinical Hypertension, Vol 24, Iss 5, Pp 621-629 (2022)
Abstract This retrospective multi‐institutional database analysis aimed to evaluate the blood‐pressure‐lowering efficacy and clinical outcomes of a generic versus brand‐name nifedipine for hypertension management. A total of 12 693 patients w
Externí odkaz:
https://doaj.org/article/6cae6df375f24cda849eb86e5858f03e
Autor:
Ying‐Chang Tung, Tzyy‐Jer Hsu, Chia‐Pin Lin, Fu‐Chih Hsiao, You‐Chia Chu, Wen‐Jone Chen, Pao‐Hsien Chu
Publikováno v:
J Clin Hypertens (Greenwich)
The cover image is based on the Original Article Efficacy and safety outcomes of one generic nifedipine versus ADALAT long‐acting nifedipine for hypertension management by Ying‐Chang Tung et al., https://doi.org/10.1111/jch.14070. [Image: see tex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109c31313f9c6d58321e76bf329f296f
https://doi.org/10.1111/jch.14139
https://doi.org/10.1111/jch.14139
Autor:
Chia‐Pin Lin, Ying‐Chang Tung, Fu‐Chih Hsiao, Chia‐Hung Yang, Yi‐Wei Kao, Yu‐Sheng Lin, You‐Chia Chu, Pao‐Hsien Chu
Publikováno v:
J Clin Hypertens (Greenwich)
The cover image is based on the Original Paper Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia by Chia‐Pin Lin, Ying‐Chang Tung et al., https://doi.org/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8234b5fc4e377677355d4ed48f0d73c1
https://europepmc.org/articles/PMC8029909/
https://europepmc.org/articles/PMC8029909/
Autor:
Fu-Chih Hsiao, You-Chia Chu, Pao-Hsien Chu, Ying-Chang Tung, Tzyy-Jer Hsu, Wen-Jone Chen, Chia-Pin Lin
Publikováno v:
J Clin Hypertens (Greenwich)
Data regarding the long-term outcomes of generic antihypertensive drugs are limited. This nationwide retrospective database analysis aimed to evaluate the efficacy and safety of a generic versus brand-name nifedipine for hypertension treatment. Patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f24a1d65b74e3efb8b33531a9560a5
https://europepmc.org/articles/PMC8029800/
https://europepmc.org/articles/PMC8029800/
Autor:
Fu-Chih Hsiao, You-Chia Chu, Chia-Hung Yang, Pao-Hsien Chu, Ying-Chang Tung, Yu-Sheng Lin, Yi-Wei Kao, Chia-Pin Lin
Publikováno v:
J Clin Hypertens (Greenwich)
Hypertension and dyslipidemia are important risk factors for cardiovascular disease. However, the clinical outcomes of fixed-dose combination (FDC) versus free-equivalent combination (FEC) of amlodipine and atorvastatin in the treatment of concurrent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73abbb75f14fe60677a07ecfa7b8b4ae
https://pubmed.ncbi.nlm.nih.gov/32862551
https://pubmed.ncbi.nlm.nih.gov/32862551